SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL OMB Number: 3235-0104 Estimated average burden hours per response: 0.5

1. Name and Address of Reporting Person* Trahan Jeremy (Last) (First) (Middle) 625 E. KALISTE SALOOM RD. (Street) LAFAYETTE LA 70508 (City) (State) (Zip)	2. Date of Event Requiring Statement (Month/Day/Year) 11/08/2023	3. Issuer Name and Ticker or Trading Symbol VIEMED HEALTHCARE, INC. [ VMD ]
		4. Relationship of Reporting Person(s) to Issuer (Check all applicable) Director 10% Owner X Officer (give title below) Other (specify below) Chief Legal Officer	5. If Amendment, Date of Original Filed (Month/Day/Year)
			6. Individual or Joint/Group Filing (Check Applicable Line) X Form filed by One Reporting Person Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Shares	3,789	D

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Options	(1)	08/22/2032	Common Shares	26,125	$6.34	D
Phantom Share Units	(2)	08/22/2025	Common Shares	5,972	(3)	D
Restricted Stock Units	(4)	08/22/2025	Common Shares	11,943	(5)	D
Phantom Share Units	(6)	01/17/2026	Common Shares	3,663	(3)	D
Restricted Stock Units	(7)	01/17/2026	Common Shares	14,653	(5)	D

Explanation of Responses:

1. Options granted to reporting person on August 22, 2022, which vest in three equal annual installments beginning on the first anniversary of the grant date.

2. Represents an award granted on August 22, 2022 under the Issuer's Phantom Share Unit Plan which vests equally on August 22, 2024 and August 22, 2025.

3. Each phantom share unit represents a right to receive the cash value of one share of the Issuer's common shares which will be determined based on the Issuer's share price on the vesting date.

4. Restricted Stock Units (RSUs) granted to reporting person on August 22, 2022, which vest equally on August 22, 2024 and August 22, 2025.

5. Each Restricted Stock Unit (RSU) represents a contingent right to receive one common share.

6. Represents an award granted on January 17, 2023 under the Issuer's Phantom Share Unit Plan which vests in three equal annual installments beginning on the first anniversary of the grant date.

7. Restricted Stock Units (RSUs) granted to reporting person on January 17, 2023, which vest in three equal annual installments beginning on the first anniversary of the grant date.

Remarks:

Exhibit List: Exhibit 24 Limited Power of Attorney

	/s/ Jesse Bergeron, Attorney-in-Fact	11/09/2023
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.